tiprankstipranks
Celcuity Inc. (CELC)
NASDAQ:CELC
US Market
CELC
Celcuity
RESEARCH TOOLSreports
Want to see CELC full AI Analyst Report?

Celcuity (CELC) Stock Forecast & Price Target

552 Followers
See the Price Targets and Ratings of:

CELC Analyst Ratings

Strong Buy
10Ratings
Strong Buy
10 Buy
0 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Celcuity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CELC Stock 12 Month Forecast

Average Price Target

$160.89
▲(94.73% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Celcuity in the last 3 months. The average price target is $160.89 with a high forecast of $177.00 and a low forecast of $140.00. The average price target represents a 94.73% change from the last price of $82.62.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"$38","73":"$73","108":"$108","143":"$143","178":"$178"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":177,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$177.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":160.88888888888889,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$160.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$140.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,73,108,143,178],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.38,93.35076923076923,100.32153846153845,107.29230769230769,114.26307692307692,121.23384615384614,128.20461538461538,135.17538461538462,142.14615384615385,149.11692307692306,156.0876923076923,163.05846153846153,170.02923076923076,{"y":177,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.38,92.11145299145299,97.84290598290598,103.57435897435897,109.30581196581196,115.03726495726495,120.76871794871795,126.50017094017093,132.23162393162391,137.96307692307693,143.6945299145299,149.4259829059829,155.1574358974359,{"y":160.88888888888889,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.38,90.50461538461538,94.62923076923076,98.75384615384615,102.87846153846154,107.00307692307692,111.12769230769231,115.2523076923077,119.37692307692308,123.50153846153846,127.62615384615384,131.75076923076924,135.87538461538463,{"y":140,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.22,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.16,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.48,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.34,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.93,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.65,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.96,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.49,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.38,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$177.00Average Price Target$160.89Lowest Price Target$140.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CELC
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
$178→$173
Buy
109.39%
Upside
Reiterated
08/18/26
Craig-Hallum Sticks to Its Buy Rating for Celcuity (CELC)
Guggenheim Analyst forecast on CELC
Bradley Canino
Guggenheim
Guggenheim
$165→$175
Buy
111.81%
Upside
Assigned
08/16/26
Celcuity price target raised to $175 from $165 at GuggenheimCelcuity price target raised to $175 from $165 at Guggenheim
Wells Fargo Analyst forecast on CELC
Eva Fortea Verdejo
Wells Fargo
Wells Fargo
$166
Buy
100.92%
Upside
Reiterated
08/14/26
Wells Fargo Reaffirms Their Buy Rating on Celcuity (CELC)
LifeSci Capital Analyst forecast on CELC
Oliver McCammon
LifeSci Capital
LifeSci Capital
$165
Buy
99.71%
Upside
Reiterated
08/14/26
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
Needham Analyst forecast on CELC
Gil Blum
Needham
Needham
$140
Buy
69.45%
Upside
Assigned
08/14/26
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
Stifel Nicolaus Analyst forecast on CELC
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
$175→$150
Buy
81.55%
Upside
Reiterated
08/14/26
Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)
TD Cowen Analyst forecast on CELC
Tara Bancroft
TD Cowen
TD Cowen
―
Buy
―
Reiterated
08/13/26
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
H.C. Wainwright Analyst forecast on CELC
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$155
Buy
87.61%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NASDAQ: NMRA), Celcuity (NASDAQ: CELC) and Parabilis Medicines, Inc. (NASDAQ: PBLS)
Leerink Partners Analyst forecast on CELC
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$157→$147
Buy
77.92%
Upside
Reiterated
07/17/26
Celcuity (CELC) Receives a Buy from Leerink Partners
Citizens JMP Analyst forecast on CELC
Silvan Turkcan
Citizens JMP
Citizens JMP
$160→$177
Buy
114.23%
Upside
Reiterated
07/15/26
Celcuity price target raised to $177 from $160 at CitizensCelcuity price target raised to $177 from $160 at Citizens
Wolfe Research Analyst forecast on CELC
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
$110
Buy
33.14%
Upside
Initiated
11/17/25
Celcuity initiated with an Outperform at Wolfe ResearchCelcuity initiated with an Outperform at Wolfe Research
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CELC
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
$178→$173
Buy
109.39%
Upside
Reiterated
08/18/26
Craig-Hallum Sticks to Its Buy Rating for Celcuity (CELC)
Guggenheim Analyst forecast on CELC
Bradley Canino
Guggenheim
Guggenheim
$165→$175
Buy
111.81%
Upside
Assigned
08/16/26
Celcuity price target raised to $175 from $165 at GuggenheimCelcuity price target raised to $175 from $165 at Guggenheim
Wells Fargo Analyst forecast on CELC
Eva Fortea Verdejo
Wells Fargo
Wells Fargo
$166
Buy
100.92%
Upside
Reiterated
08/14/26
Wells Fargo Reaffirms Their Buy Rating on Celcuity (CELC)
LifeSci Capital Analyst forecast on CELC
Oliver McCammon
LifeSci Capital
LifeSci Capital
$165
Buy
99.71%
Upside
Reiterated
08/14/26
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
Needham Analyst forecast on CELC
Gil Blum
Needham
Needham
$140
Buy
69.45%
Upside
Assigned
08/14/26
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
Stifel Nicolaus Analyst forecast on CELC
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
$175→$150
Buy
81.55%
Upside
Reiterated
08/14/26
Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)
TD Cowen Analyst forecast on CELC
Tara Bancroft
TD Cowen
TD Cowen
―
Buy
―
Reiterated
08/13/26
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
H.C. Wainwright Analyst forecast on CELC
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$155
Buy
87.61%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NASDAQ: NMRA), Celcuity (NASDAQ: CELC) and Parabilis Medicines, Inc. (NASDAQ: PBLS)
Leerink Partners Analyst forecast on CELC
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$157→$147
Buy
77.92%
Upside
Reiterated
07/17/26
Celcuity (CELC) Receives a Buy from Leerink Partners
Citizens JMP Analyst forecast on CELC
Silvan Turkcan
Citizens JMP
Citizens JMP
$160→$177
Buy
114.23%
Upside
Reiterated
07/15/26
Celcuity price target raised to $177 from $160 at CitizensCelcuity price target raised to $177 from $160 at Citizens
Wolfe Research Analyst forecast on CELC
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
$110
Buy
33.14%
Upside
Initiated
11/17/25
Celcuity initiated with an Outperform at Wolfe ResearchCelcuity initiated with an Outperform at Wolfe Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Celcuity

3 Months
Oliver McCammonLifeSci Capital
Success Rate
10/12 ratings generated profit
83%
Average Return
+71.49%
Copying Oliver McCammon's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +71.49% per trade.
1 Year
Oliver McCammonLifeSci Capital
Success Rate
9/12 ratings generated profit
75%
Average Return
+256.70%
Copying Oliver McCammon's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +256.70% per trade.
2 Years
Gil BlumNeedham
Success Rate
20/23 ratings generated profit
87%
Average Return
+286.32%
Copying Gil Blum's trades and holding each position for 2 Years would result in 86.96% of your transactions generating a profit, with an average return of +286.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CELC Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
1
6
13
20
Buy
11
26
17
19
4
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
28
23
32
24
In the current month, CELC has received 24 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CELC average Analyst price target in the past 3 months is 160.89.
Each month's total comprises the sum of three months' worth of ratings.

CELC Financial Forecast

CELC Earnings Forecast

Next quarter’s earnings estimate for CELC is -$1.41 with a range of -$1.75 to -$1.10. The previous quarter’s EPS was -$1.44. CELC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.
Next quarter’s earnings estimate for CELC is -$1.41 with a range of -$1.75 to -$1.10. The previous quarter’s EPS was -$1.44. CELC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.
No data currently available

CELC Sales Forecast

Next quarter’s sales forecast for CELC is $4.26M with a range of $0.00 to $9.90M. The previous quarter’s sales results were $0.00. CELC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.
Next quarter’s sales forecast for CELC is $4.26M with a range of $0.00 to $9.90M. The previous quarter’s sales results were $0.00. CELC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CELC has Performed in-line its overall industry.

CELC Stock Forecast FAQ

What is CELC’s average 12-month price target, according to analysts?
Based on analyst ratings, Celcuity Inc.’s 12-month average price target is 160.89.
    What is CELC’s upside potential, based on the analysts’ average price target?
    Celcuity Inc. has 94.73% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CELC a Buy, Sell or Hold?
          Celcuity Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Celcuity Inc.’s price target?
            The average price target for Celcuity Inc. is 160.89. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $177.00 ,the lowest forecast is $140.00. The average price target represents 94.73% Increase from the current price of $82.62.
              What do analysts say about Celcuity Inc.?
              Celcuity Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of CELC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.